产品封面图

ZR-75-30

收藏
  • 询价
  • 2026年01月05日
    avatar
    15金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 器官来源

      乳房

    • 生长状态

      贴壁生长

    • 物种来源

    • 是否是肿瘤细胞

      1

    • 细胞类型

      上皮细胞

    • 相关疾病

      导管癌

    • ATCC Number

      CRL-1504™

    • 库存

      大量

    • 年限

      47 years

    • 运输方式

      冻存运输

    • 细胞形态

      上皮样

    Designations: ZR-75-30
    Depositors:  LW Engel
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Homo sapiens
    Morphology: epithelial

    Source: Organ: mammary gland; breast
    Disease: ductal carcinoma
    Derived from metastatic site: ascites
    Cell Type: epithelial
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    DNA Profile (STR): Amelogenin: X
    CSF1PO: 10,11
    D13S317: 10,11
    D16S539: 9
    D5S818: 12,13
    D7S820: 11,12
    THO1: 8,9
    TPOX: 10,11
    vWA: 18,19
    Cytogenetic Analysis: This is a hypertriploid human cell line. The modal chromosome number was 80, occurring in 40% of cells. The rate of cells with higher ploidies was 1.2%. Sixteen marker chromosomes were found in most cells.
    Age: 47 years
    Gender: female
    Ethnicity: Black
    Comments: ZR-75-30 was derived from malignant ascites fluid from a 47-year-old premenopausal Black woman with infiltrating ductal carcinoma. These cells have been characterized to be human, non-HeLa, malignant mammary epithelium in origin.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Atmosphere: air, 95%; carbon dioxide (CO2), 5%
    Temperature: 37.0°C
    Subculturing: Protocol:
    1. Remove and discard culture medium.
    2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
    3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.
    4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    5. Add appropriate aliquots of the cell suspension to new culture vessels.
    6. Incubate cultures at 37�C.

    Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:3 is recommended
    Medium Renewal: 2 to 3 times per week
    Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
    Storage temperature: liquid nitrogen vapor phase
    Doubling Time: 110 hrs
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
    recommended serum:ATCC 30-2020
    purified DNA:ATCC 45532
    purified DNA:ATCC 45533
    purified DNA:ATCC CRL-1504D
    References: 1230: Engel LW, Young NA. Human breast carcinoma cells in continuous culture: a review. Cancer Res. 38: 4327-4339, 1978. PubMed: 212193
    23031: Engel LW, et al. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res. 38: 3352-3364, 1978. PubMed: 688225
    32275: Littlewood-Evans AJ, et al. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 57: 5386-5390, 1997. PubMed: 9393764

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • 人乳腺癌的裸鼠移植模型的制作

      HBC裸鼠移植模型的建立包括活检取材的HBC标本和细胞株,后者应用较广泛。本贴主要讨论后者,算是抛砖了!1、人乳腺癌细胞株的选择目前人乳腺癌细胞建株的癌细胞较多,本人曾接触过细胞株总结如下:ER(+):MCF-7(来源:乳腺腺癌),ZR-75-30(乳腺导管癌),T47D(乳腺导管癌),ZR-75(乳腺腺癌)。ER(-):MDA-MB-435s(乳腺导管癌),MDA-MB-435(乳腺导管癌),SK-BR-3 (乳腺腺癌),MDA-MB-231(乳腺腺癌),MDA-MB-453(乳腺

    • 氧化锆色谱柱的主要性能特点

      300 30     0-14 200 ZR02 ZirChrom-PHASE 常规

    • F值表(方差齐性检验用)

      4.32 3.72 3.38 3.15 2.99 2.87 2.78 2.70 2.64 2.54 2.44 2.33 2.21 2.08 1.93 24 25 4.29 3.69 3.35 3.13 2.97 2.85 2.75 2.68 2.61 2.51 2.41 2.30 2.18 2.05 1.91 25 26 4.26 3.67 3.33 3.10 2.94 2.82 2.73 2.65 2.59 2.49 2.39 2.28 2.16 2.03 1.88 26

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1280
    上海康朗生物科技有限公司
    2026年01月08日询价
    ¥680
    上海联迈生物工程有限公司
    2025年07月14日询价
    ¥600
    上海信裕生物科技有限公司
    2025年07月09日询价
    ¥600
    上海再康生物科技有限公司
    2025年11月21日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月06日询价
    ZR-75-30
    询价